Satu Koskela
Overview
Explore the profile of Satu Koskela including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ritari J, Koskela S, Hyvarinen K, FinnGen , Ollila H, Partanen J
Hum Immunol
. 2024 Nov;
85(6):111177.
PMID: 39546901
Allelic, gene presence/absence, and gene-copy number variations in the KIR genes encoding Natural Killer (NK) cell surface receptors have been reported to be associated in case-control studies with infectious and...
2.
Nihtila J, Penna L, Salmenniemi U, Itala-Remes M, Crossland R, Gallardo D, et al.
Sci Rep
. 2024 Nov;
14(1):26988.
PMID: 39506082
Natural killer (NK) cells recognize and may kill malignant cells via their cell surface receptors. Killer cell immunoglobulin-like receptor (KIR) genotypes of donors have been reported to adjust the risk...
3.
Escriba R, Beksac M, Bennaceur-Griscelli A, Glover J, Koskela S, Latsoudis H, et al.
Stem Cell Rev Rep
. 2024 Oct;
21(1):290.
PMID: 39422809
No abstract available.
4.
Tammi S, Koskela S, Hyvarinen K, Partanen J, Ritari J
PLoS Comput Biol
. 2024 Sep;
20(9):e1011718.
PMID: 39283896
In addition to the classical HLA genes, the major histocompatibility complex (MHC) harbors a high number of other polymorphic genes with less established roles in disease associations and transplantation matching....
5.
Escriba R, Beksac M, Bennaceur-Griscelli A, Glover J, Koskela S, Latsoudis H, et al.
Stem Cell Rev Rep
. 2024 Sep;
20(8):2155-2164.
PMID: 39276260
The use of allogeneic induced pluripotent stem cell (iPSC)-derived cell therapies for regenerative medicine offers an affordable and realistic alternative to producing individual iPSC lines for each patient in need....
6.
Pollock N, Farias T, Kichula K, Sauter J, Scholz S, Nii-Trebi N, et al.
HLA
. 2024 Jun;
103(6):e15568.
PMID: 38923286
No abstract available.
7.
Clancy J, Ritari J, Vaittinen E, Arvas M, Tammi S, Koskela S, et al.
Eur J Hum Genet
. 2024 Jan;
PMID: 38212662
Health questionnaires and donation criteria result in accumulation of highly selected individuals in a blood donor population. To understand better the usefulness of a blood donor-based biobank in personalised disease-associated...
8.
Silva N, Bourguiba-Hachemi S, Douillard V, Koskela S, Degenhardt F, Clancy J, et al.
HLA
. 2023 Nov;
103(1):e15293.
PMID: 37947386
The SNP-HLA Reference Consortium (SHLARC), a component of the 18th International HLA and Immunogenetics Workshop, is aimed at collecting diverse and extensive human leukocyte antigen (HLA) data to create custom...
9.
Chiaro J, Antignani G, Feola S, Feodoroff M, Martins B, Cojoc H, et al.
Nat Commun
. 2023 Nov;
14(1):7056.
PMID: 37923723
Malignant pleural mesothelioma (MPM) is an aggressive tumor with a poor prognosis. As the available therapeutic options show a lack of efficacy, novel therapeutic strategies are urgently needed. Given its...
10.
Koskela S, Tammi S, Clancy J, Lucas J, Turner T, Hyvarinen K, et al.
HLA
. 2023 Mar;
102(1):52-61.
PMID: 36919857
Genetic variation in the MICA and MICB genes located within the major histocompatibility complex region has been reported to be associated with transplantation outcome and susceptibility to autoimmune diseases and...